Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2013 | 2 |
2017 | 1 |
2019 | 1 |
2022 | 1 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
IPF Respiratory Symptoms Management - Current Evidence.
Front Med (Lausanne). 2022 Jul 28;9:917973. doi: 10.3389/fmed.2022.917973. eCollection 2022.
Front Med (Lausanne). 2022.
PMID: 35966835
Free PMC article.
Review.
Atypical manifestations of granulomatosis with polyangiitis: the diagnostic challenge for pulmonologists.
Szymanowska-Narloch A, Gawryluk D, Błasińska-Przerwa K, Siemińska A.
Szymanowska-Narloch A, et al.
Adv Respir Med. 2019;87(6):244-253. doi: 10.5603/ARM.2019.0062.
Adv Respir Med. 2019.
PMID: 31970726
Free article.
Review.
Item in Clipboard
Main histologic types of non-small-cell lung cancer differ in expression of prognosis-related genes.
Skrzypski M, Dziadziuszko R, Jassem E, Szymanowska-Narloch A, Gulida G, Rzepko R, Biernat W, Taron M, Jelitto-Górska M, Marjański T, Rzyman W, Rosell R, Jassem J.
Skrzypski M, et al. Among authors: szymanowska narloch a.
Clin Lung Cancer. 2013 Nov;14(6):666-673.e2. doi: 10.1016/j.cllc.2013.04.010. Epub 2013 Jul 17.
Clin Lung Cancer. 2013.
PMID: 23870818
Item in Clipboard
Molecular profiles of non-small cell lung cancers in cigarette smoking and never-smoking patients.
Szymanowska-Narloch A, Jassem E, Skrzypski M, Muley T, Meister M, Dienemann H, Taron M, Rosell R, Rzepko R, Jarząb M, Marjański T, Pawłowski R, Rzyman W, Jassem J.
Szymanowska-Narloch A, et al.
Adv Med Sci. 2013;58(2):196-206. doi: 10.2478/ams-2013-0025.
Adv Med Sci. 2013.
PMID: 24451080
Item in Clipboard
Osimertinib - effective treatment of NSCLC with activating EGFR mutations after progression on EGFR tyrosine kinase inhibitors.
Skrzypski M, Szymanowska-Narloch A, Dziadziuszko R.
Skrzypski M, et al. Among authors: szymanowska narloch a.
Contemp Oncol (Pozn). 2017;21(3):254-258. doi: 10.5114/wo.2017.70116. Epub 2017 Sep 29.
Contemp Oncol (Pozn). 2017.
PMID: 29180936
Free PMC article.
Item in Clipboard
Cite
Cite